Cargando…
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment
Reference pricing and health technology assessment are policies commonly applied in order to obtain more value for money from pharmaceuticals. This study focussed on decisions about the initial price and reimbursement status of innovative drugs and discussed the consequences for market access and co...
Autores principales: | Drummond, Michael, Jönsson, Bengt, Rutten, Frans, Stargardt, Tom |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078322/ https://www.ncbi.nlm.nih.gov/pubmed/20803050 http://dx.doi.org/10.1007/s10198-010-0274-y |
Ejemplares similares
-
Does health technology assessment compromise access to pharmaceuticals?
por: Büssgen, Melanie, et al.
Publicado: (2022) -
Does health technology assessment compromise access to pharmaceuticals?
por: Büssgen, Melanie, et al.
Publicado: (2023) -
Pharmaceutical pricing and reimbursement policies: perspectives for the future
por: Gray, Andrew L
Publicado: (2015) -
Challenges and opportunities for pharmaceutical pricing and reimbursement policies
por: Vogler, Sabine, et al.
Publicado: (2015) -
Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs
por: Docteur, Elizabeth, et al.
Publicado: (2015)